News & Events

The Firm is representing Goldman, Sachs & Co. as financial advisor to Hologic, Inc, in its acquisition of Gen-Probe Incorporated.  Under the terms of the agreement, Hologic will acquire all of the outstanding shares of Gen-Probe for $82.75 per share in cash, or a total enterprise value at approximately $3.7 billion.  The transaction is expected to close in the second half of 2012, subject to customary closing conditions.

Hologic (NASDAQ: HOLX)  is a leading developer, manufacturer and supplier of premium diagnostics products, medical imaging systems and surgical products dedicated to serving the healthcare needs of women. Gen-Probe (NASDAQ: GPRO) is a global leader in the development, manufacture and marketing of rapid, accurate and cost-effective molecular diagnostic products and services that are used primarily to diagnose human diseases, screen donated human blood, and ensure transplant compatibility.

The Simpson Thacher team includes Rob Spatt, Brian Stadler, Thomas Lamprecht and Matt Rogers.